- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
New antibiotic combination may help save lives of patients with cystic fibrosis
A new antibiotic combination developed by researchers at Aston University has formed part of a lifesaving treatment used in the USA. The antibiotic combination of imipenem/relebactam with amoxicillin was discovered to be highly effective against potentially deadly Mycobacterium abscessus - a bacterium that can cause serious lung infections in people with various chronic lung diseases such...
A new antibiotic combination developed by researchers at Aston University has formed part of a lifesaving treatment used in the USA.
The antibiotic combination of imipenem/relebactam with amoxicillin was discovered to be highly effective against potentially deadly Mycobacterium abscessus - a bacterium that can cause serious lung infections in people with various chronic lung diseases such as cystic fibrosis
The discovery was made by a team led by Dr Jonathan Cox, senior lecturer in microbiology in Aston University's College of Health and Life Sciences. This combination has been used as part of the treatment for a patient in America, who subsequently recovered from their infection.
The patient, who has cystic fibrosis, received the Aston University combination of antibiotics as part of a complex treatment regime, including an experimental therapy known as phage therapy, which uses viruses to treat bacterial infections.
The combination successfully treated the patient's infection and resulted in their being able to receive a live-saving lung transplant.
A paper which describes the treatment has been published in the journal Cell, and states: "The combination of phage and antibiotics did not result in greater antibiotic resistance." This means that the combined treatment was successful at eradicating the infection and enabling the patient to receive the lifesaving lung transplant.
Dr Jonathan Cox said:
"The successful treatment of this patient with the combination of antibiotics and phage demonstrates the impact of this combined approach for tackling antibiotic resistant Mycobacterium abscessus.
For further reference log on to:
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: editorial@medicaldialogues.in. Contact no. 011-43720751